RYTM vs. VGT

In the year-to-date period, RYTM achieves a 9.56% return, which is significantly higher than VGT's -2.36% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Rhythm Pharmaceuticals, Inc. (RYTM) and Vanguard Information Technology ETF (VGT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RYTM Sharpe Ratio is 1.33, which is higher than the VGT Sharpe Ratio of 0.47. The chart below compares the historical Sharpe Ratios of RYTM and VGT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

RYTM has not paid dividends to shareholders, while VGT's dividend yield for the trailing twelve months is around 0.53%.

The maximum RYTM drawdown since its inception was -92.10%, which is greater than VGT's maximum drawdown of -54.63%. Use the drawdown chart below to compare losses from any high point for RYTM and VGT.

Rhythm Pharmaceuticals, Inc. (RYTM) has a higher volatility of 14.80% compared to Vanguard Information Technology ETF (VGT) at 6.70%. This indicates that RYTM's price experiences larger fluctuations and is considered to be riskier than VGT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.